RIM
VRTX icon

Redpoint Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Redpoint Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.72M Sell
5,950
-1,031
-15% -$297K 0.25% 95
2022
Q2 		$1.97M Sell
6,981
-75
-1% -$20.1K 0.23% 98
2022
Q1 		$1.84M Sell
7,056
-131
-2% -$31.1K 0.18% 127
2021
Q4 		$1.58M Hold
7,187
– – 0.13% 189
2021
Q3 		$1.3M Sell
7,187
-141
-2% -$27.5K 0.11% 212
2021
Q2 		$1.48M Buy
7,328
+101
+1% +$21.1K 0.12% 207
2021
Q1 		$1.55M Buy
7,227
+468
+7% +$103K 0.13% 183
2020
Q4 		$1.6M Sell
6,759
-456
-6% -$105K 0.16% 154
2020
Q3 		$1.96M Sell
7,215
-12,000
-62% -$3.31M 0.21% 111
2020
Q2 		$5.58M Sell
19,215
-1,414
-7% -$383K 0.31% 73
2020
Q1 		$4.91M Sell
20,629
-167
-0.8% -$38.3K 0.31% 77
2019
Q4 		$4.55M Sell
20,796
-618
-3% -$125K 0.22% 114
2019
Q3 		$3.63M Sell
21,414
-380
-2% -$67.2K 0.19% 135
2019
Q2 		$4M Sell
21,794
-288
-1% -$50.3K 0.21% 118
2019
Q1 		$4.06M Buy
22,082
+1,119
+5% +$207K 0.2% 124
2018
Q4 		$3.47M Hold
20,963
– – 0.2% 130
2018
Q3 		$4.04M Hold
20,963
– – 0.2% 123
2018
Q2 		$3.56M Buy
20,963
+469
+2% +$72.7K 0.19% 140
2018
Q1 		$3.34M Hold
20,494
– – 0.19% 152
2017
Q4 		$3.07M Buy
+20,494
New +$3.03M 0.17% 168

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Redpoint Investment Management's VRTX Position: Q3 2022 in Review

Redpoint Investment Management reduced its Vertex Pharmaceuticals (VRTX) stake by 15% in Q3 2022, selling an estimated $297K and leaving 5,950 shares worth $1.72M. The position accounts for 0.25% of the portfolio, ranked #95.

Redpoint Investment Management first reported a position in VRTX in Q4 2017 and has held it in 20 quarters since. The position peaked at $5.58M in Q2 2020. 1,124 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.

  • Redpoint Investment Management held 5,950 shares of Vertex Pharmaceuticals worth $1.72M as of Q3 2022.
  • Redpoint Investment Management sold 1,031 Vertex Pharmaceuticals shares in Q3 2022, an estimated $297K.
  • Vertex Pharmaceuticals made up 0.25% of Redpoint Investment Management's portfolio in Q3 2022, its #95 holding.
  • Redpoint Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • Redpoint Investment Management's Vertex Pharmaceuticals position peaked at $5.58M in Q2 2020.
  • 1,124 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.